Monoclonal antibodies: There’s also no beneficiary cost sharing and no deductible for COVID-19 monoclonal antibody products when providers administer them.
Covid oral antiviral: There’s also no beneficiary cost sharing and no deductible for COVID-19 oral antivirals.
Covid home tests are covered under 20% Co insurance under Part B
Vaccines are covered at 0 cost share under Part B
Other previsions may end that were previously allowed under the PHE.